Tilray Brands (TLRY) Common Equity (2017 - 2026)
Tilray Brands (TLRY) reported Common Equity of $1.6 billion for Q1 2026, down 42.36% on a YoY basis from $2.7 billion in Q1 2025, and up 0.7% quarter-over-quarter from $1.5 billion in Q4 2025.
Tilray Brands (TLRY) Common Equity (2017 - 2026) Analysis & Trends
Tilray Brands has reported Common Equity for 10 years, with the latest figure at $1.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 42.36% year-over-year to $1.6 billion; the trailing twelve-month figure through Feb 2026 stood at $1.6 billion (down 42.36% YoY), and the FY2025 full-year result was $1.5 billion, down 56.1% from the prior year.
- Common Equity for Q1 2026 stood at $1.6 billion, up from $1.5 billion in the prior quarter.
- The five-year high for Common Equity was $4.7 billion in Q1 2022, with the low at $1.5 billion in Q2 2025.
- Historically, Common Equity has averaged $3.2 billion across 5 years, with a median of $3.4 billion in 2023.
- Annual changes were most pronounced in 2022 — Common Equity jumped 327.74% — and 2025, when it plunged 56.35%.
- Tilray Brands' Common Equity stood at $4.5 billion in 2022, then fell by 24.31% to $3.4 billion in 2023, then increased by 1.78% to $3.5 billion in 2024, then sank by 55.22% to $1.5 billion in 2025, then rose by 0.7% to $1.6 billion in 2026.
- The last three Common Equity figures came in at $1.6 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 1.56 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.56 Bn |
| Nov 30, 2025 | 1.55 Bn |
| Aug 31, 2025 | 1.52 Bn |
| May 31, 2025 | 1.51 Bn |
| Feb 28, 2025 | 2.70 Bn |
| Nov 30, 2024 | 3.45 Bn |
| Aug 31, 2024 | 3.48 Bn |
| May 31, 2024 | 3.44 Bn |
| Feb 29, 2024 | 3.34 Bn |
| Nov 30, 2023 | 3.39 Bn |
| Aug 31, 2023 | 3.40 Bn |
| May 31, 2023 | 3.33 Bn |
| Feb 28, 2023 | 3.41 Bn |
| Nov 30, 2022 | 4.48 Bn |
| Aug 31, 2022 | 4.56 Bn |
| May 31, 2022 | 4.44 Bn |
| Feb 28, 2022 | 4.66 Bn |
| Nov 30, 2021 | 4.47 Bn |
| Aug 31, 2021 | 4.39 Bn |
| May 31, 2021 | 4.47 Bn |